Abstract
Sex differences exist in many neurological and psychiatric diseases. Mandates have been initiated across funding agencies for research to include males and females. What has been lacking in the literature is a detailed assessment of how sex is incorporated into the design (e.g. balanced design) and into the analyses (e.g. covariate). We surveyed papers in 2009 and 2019 across six journals in Neuroscience and Psychiatry. There was a 30% increase in the percentage of papers that included both sexes to 68% in 2019. Despite this increase, in 2019 only 19% of studies used an optimal design for discovery of possible sex differences and only 5% analyzed sex as a discovery variable. Here we show that little progress has been made in harnessing the power that sex differences can afford in research for discovery and therapeutic potential for neurological and psychiatric disease to improve the health of men, women and gender diverse individuals.
Highlights
68% of Neuroscience and Psychiatry papers reported the use of both sexes in 2019
Only 19% of studies in 2019 used sex consistently throughout the study analyses
Of the studies that used males and females, 59% did not include sex in the analyses
Only 5% of studies in 2019 used sex as a discovery variable in their analyses
Male only papers were 8.4 times more prevalent than female-only papers
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
two new analyses, shortened paper and new section in discussion.
